Bayer Cash on Hand 2010-2024 | BAYRY | MacroTrends

Bayer Cash on Hand 2010-2024 | BAYRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bayer cash on hand for the quarter ending September 30, 2024 was $6.970B, a 31.18% decline year-over-year.

Bayer cash on hand for 2023 was $11.627B, a 6.33% increase from 2022.
Bayer cash on hand for 2022 was $10.935B, a 16.91% increase from 2021.
Bayer cash on hand for 2021 was $9.354B, a 32.5% decline from 2020.

Bayer Cash on Hand 2010-2024 | BAYRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bayer cash on hand for 2023 was $11.627B, a 6.33% increase from 2022.
Bayer cash on hand for 2022 was $10.935B, a 16.91% increase from 2021.
Bayer cash on hand for 2021 was $9.354B, a 32.5% decline from 2020.

Related Stocks
Company Name	Market Cap
Eli Lilly (LLY)	$759.4B
Novo Nordisk (NVO)	$387.1B
Johnson & Johnson (JNJ)	$342B
AbbVie (ABBV)	$309.5B
Merck (MRK)	$251.1B
AstraZeneca (AZN)	$207.8B
Novartis AG (NVS)	$202.5B
Pfizer (PFE)	$151.4B
Sanofi (SNY)	$123.7B
Innoviva (INVA)	$1.1B